KRAS and lung adenocarcinoma: Although direct evidence regarding the interaction between SOX9 and the EGFR/KRAS pathways in lung adenocarcinoma remains limited, studies in other types of cancer suggest that SOX9 may regulate the biological behavior of lung adenocarcinoma cells through crosstalk with these signaling pathways (42–44).